DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Pentastarch is an investigational drug.
There have been 5 clinical trials for Pentastarch. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2011.
The most common disease conditions in clinical trials are Shock, Shock, Hemorrhagic, and Acidosis, Lactic. The leading clinical trial sponsors are Sangart, Hamilton Health Sciences Corporation, and Ottawa Hospital Research Institute.
Recent Clinical Trials for Pentastarch
|Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients||Sangart||Phase 2|
|Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients||Sangart||Phase 2|
|Fluid Resuscitation in Early Septic Shock||Baxter Healthcare Corporation||Phase 2|